Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis

被引:91
作者
Giles, R. H.
Lolkema, M. P.
Snijckers, C. M.
Belderbos, M.
van der Groep, P.
Mans, D. A.
van Beest, M.
van Noort, M.
Goldschmeding, R.
van Diest, P. J.
Clevers, H.
Voest, E. E.
机构
[1] Univ Utrecht, Med Ctr, Dept Med Oncol, Expt Oncol Lab, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Pathol, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Urol, Utrecht, Netherlands
[4] NIOB, Hubrecht Lab, Utrecht, Netherlands
关键词
von Hippel-Lindau; Wnt signaling; hypoxiainducible factor; colorectal cancer;
D O I
10.1038/sj.onc.1209330
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the Wnt signaling pathway initiates the transformation of colorectal epithelial cells, although the transition to metastatic cancer requires angiogenesis. We have investigated the expression of the von Hippel-Lindau (VHL) tumor suppressor in the intestines from humans and mice. Here, we show that VHL expression is regulated by TCF4 and is restricted to the proliferative compartment at the bottom of intestinal crypts. Accordingly, VHL is completely absent from the proliferative intestinal pockets of Tcf4(-/-) perinatal mice. We observed complementary staining of the hypoxia-inducible factor (HIF) 1 alpha to VHL in normal intestinal epithelium as well as in all stages of colorectal cancer (CRC). To the best of our knowledge, this is the first report demonstrating the presence of nuclear HIF1 alpha in normoxic healthy adult tissue. Although we observed upregulated levels of VHL in very early CRC lesions from sporadic and familial adenomatous polyposis patients-presumably due to activated Wnt signaling - a clear reduction of VHL expression is observed in later stages of CRC progression, coinciding with stabilization of HIF1 alpha. As loss of VHL in later stages of CRC progression results in stabilization of HIF, these data provide evidence that selection for VHL downregulation provides a proangiogenic impulse for CRC progression.
引用
收藏
页码:3065 / 3070
页数:6
相关论文
共 42 条
[1]  
Aotake T, 1999, CLIN CANCER RES, V5, P135
[2]   β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB [J].
Batlle, E ;
Henderson, JT ;
Beghtel, H ;
van den Born, MMW ;
Sancho, E ;
Huls, G ;
Meeldijk, J ;
Robertson, J ;
van de Wetering, M ;
Pawson, T ;
Clevers, H .
CELL, 2002, 111 (02) :251-263
[3]   Fibronectin is a hypoxia-independent target of the tumor suppressor VHL [J].
Bluyssen, HAR ;
Lolkema, MPJK ;
van Beest, M ;
Boone, M ;
Snijckers, CMJT ;
Los, M ;
Gebbink, MFBG ;
Braam, B ;
Holstege, FCP ;
Giles, RH ;
Voest, EE .
FEBS LETTERS, 2004, 556 (1-3) :137-142
[4]   Levels of hypoxia-inducible factor-1α during breast carcinogenesis [J].
Bos, R ;
Zhong, H ;
Hanrahan, CF ;
Mommers, ECM ;
Semenza, GL ;
Pinedo, HM ;
Abeloff, MD ;
Simons, JW ;
van Diest, PJ ;
van der Wall, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :309-314
[5]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[6]   Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741
[7]  
Easwaran V, 2003, CANCER RES, V63, P3145
[8]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61
[9]   Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms [J].
Fujii, H ;
Ajioka, Y ;
Kazami, S ;
Takagaki, T ;
Zhu, XG ;
Hirose, S ;
Watanabe, H ;
Shirai, T .
JOURNAL OF PATHOLOGY, 2002, 197 (03) :298-306
[10]  
Fukuda R, 2003, CANCER RES, V63, P2330